Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of TB006 in Participants With Parkinson's Disease

NCT06773962 is registered in ClinicalTrials.gov with TrueBinding, Inc. as lead sponsor.

NCT NCT06773962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06773962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of TB006 in Participants With Parkinson's Disease
Lead sponsor
TrueBinding, Inc.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 20, 2025
Completion date
November 28, 2026
Enrollment
62 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease (pd)